Amyotrophic Lateral Sclerosis Risk for Spinocerebellar Ataxia Type 2 ATXN2 CAG Repeat Alleles A Meta-analysis

被引:62
作者
Neuenschwander, Annalese G. [1 ]
Thai, Khanh K. [1 ]
Figueroa, Karla P. [1 ]
Pulst, Stefan M. [1 ]
机构
[1] Univ Utah, Dept Neurol, Salt Lake City, UT 84132 USA
关键词
POLYGLUTAMINE EXPANSIONS; ONSET; GENE; ALS; CLONING; AGE;
D O I
10.1001/jamaneurol.2014.2082
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IMPORTANCE Repeats of CAG in the ataxin 2 gene (ATXN2) in the long-normal range (sometimes referred to as intermediate) have been identified as modifiers of amyotrophic lateral sclerosis (ALS) risk. Prior studies have used thresholding considering various cutoffs for ATXN2 repeat length. OBJECTIVE To calculate association between ATXN2 CAG repeat alleles and increased risk of ALS across multiple ethnic groups. DATA SOURCES The MEDLINE database was searched for studies published by December 29, 2013, reporting ATXN2 CAG repeat length in patients with ALS and controls. STUDY SELECTION Studies were included if they reported original data on relative risks or odds ratios (ORs) from ALS and control populations for individual ATXN2 alleles. Review articles that reported no new data were not included in the analysis. DATA EXTRACTION AND SYNTHESIS Analysis of allele distribution was performed to ensure that all studies followed identical allele sizing. The ORs, 95% confidence intervals, and population attributable risk percentages were calculated according to standard procedures. MAIN OUTCOMES AND MEASURES Occurrence of ALS associated with ATXN2 repeat alleles, expressed as ORs. RESULTS Nine studies were analyzed, including 7505 controls and 6151 sporadic ALS cases. The ALS and control cohorts were recruited from different geographical and ethnic regions including the United States, French Canada/Canada, Belgium and the Netherlands, Germany, Italy, mainland China, Turkey, and Flanders-Belgium. The ATXN2 CAG repeat lengths ranged from 13 to 39 in patients with ALS and from 13 to 34 in controls. The ORs were less than 1.00 for alleles with 25 to 28 repeats. The OR was 1.55 for 30 repeats, but this elevation was not statistically significant (95% CI, 0.88-2.73). The ORs were 2.70 (95% CI, 1.47-4.93) for 31 CAG repeats, 11.09 (95% CI, 4.16-29.57) for 32 repeats, and 5.76 (95% CI, 1.79-18.57) for 33 repeats. CONCLUSIONS AND RELEVANCE In contrast to prior studies with smaller numbers, risk for ALS associated with long-normal alleles is complex. Alleles with 27 and 28 repeats lower ALS risk slightly. The risk for ALS increases beginning with 29 repeats and reaches a maximum at 32 and 33 repeats. Of note, alleles with repeats of these lengths are known to be predisposed to meiotic expansion to full-penetrance mutant alleles. In patients with ALS, alleles with 31 to 33 repeats may have undergone preferential expansion in motor neurons during mitosis or DNA repair. Our meta-analysis provides a framework for counseling individuals with long-normal ATXN2 repeats.
引用
收藏
页码:1529 / 1534
页数:6
相关论文
共 50 条
[21]   Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2 [J].
Van Damme, P. ;
Veldink, J. H. ;
van Blitterswijk, M. ;
Corveleyn, A. ;
van Vught, P. W. J. ;
Thijs, V. ;
Dubois, B. ;
Matthijs, G. ;
van den Berg, L. H. ;
Robberecht, W. .
NEUROLOGY, 2011, 76 (24) :2066-2072
[22]   Penetrance and pleiotropy in ATXN2-related amyotrophic lateral sclerosis [J].
Douglas, Andrew G. L. .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2025,
[23]   Spinocerebellar ataxia type 2 from an evolutionary perspective: Systematic review and meta-analysis [J].
Sena, Lucas Schenatto ;
Pinheiro, Jordania dos Santos ;
Hasan, Ali ;
Saraiva-Pereira, Maria Luiza ;
Jardim, Laura Bannach .
CLINICAL GENETICS, 2021, 100 (03) :258-267
[24]   A meta-analysis on residential exposure to magnetic fields and the risk of amyotrophic lateral sclerosis [J].
Roeoesli, Martin ;
Jalilian, Hamed .
REVIEWS ON ENVIRONMENTAL HEALTH, 2018, 33 (03) :295-299
[25]   The cognitive profile of amyotrophic lateral sclerosis: A meta-analysis [J].
Raaphorst, Joost ;
De Visser, Marianne ;
Linssen, Wim H. J. P. ;
De Haan, Rob J. ;
Schmand, Ben .
AMYOTROPHIC LATERAL SCLEROSIS, 2010, 11 (1-2) :27-U17
[26]   Genomic Portrait of a Sporadic Amyotrophic Lateral Sclerosis Case in a Large Spinocerebellar Ataxia Type 1 Family [J].
Morello, Giovanna ;
Gentile, Giulia ;
Spataro, Rossella ;
Spampinato, Antonio Gianmaria ;
Guarnaccia, Maria ;
Salomone, Salvatore ;
La Bella, Vincenzo ;
Conforti, Francesca Luisa ;
Cavallaro, Sebastiano .
JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04) :1-18
[27]   Meta-analysis of social cognition in amyotrophic lateral sclerosis [J].
Bora, Emre .
CORTEX, 2017, 88 :1-7
[28]   C9orf72 and ATXN2 Repeat Expansions Coexist in a Family With Ataxia, Dementia, and Parkinsonism [J].
Zhang, Ming ;
Xi, Zhengrui ;
Misquitta, Karen ;
Sato, Christine ;
Moreno, Danielle ;
Liang, Yan ;
Slow, Elizabeth ;
Rogaeva, Ekaterina ;
Tartaglia, Maria Carmela .
MOVEMENT DISORDERS, 2017, 32 (01) :158-162
[29]   ATAXIN2 CAG-repeat length in Italian patients with amyotrophic lateral sclerosis: risk factor or variant phenotype? Implication for genetic testing and counseling [J].
Gellera, Cinzia ;
Ticozzi, Nicola ;
Pensato, Viviana ;
Nanetti, Lorenzo ;
Castucci, Alessia ;
Castellotti, Barbara ;
Lauria, Giuseppe ;
Taroni, Franco ;
Silani, Vincenzo ;
Mariotti, Caterina .
NEUROBIOLOGY OF AGING, 2012, 33 (08) :e15-e21
[30]   Type 2 diabetes mellitus, antidiabetics, and the risk of amyotrophic lateral sclerosis [J].
Yeh, Tian-Shin ;
Rotem, Ran S. ;
Weisskopf, Marc G. .
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2025,